Press Release
For immediate release
31 October 2014
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Investment Adviser
Further to the announcement on 1 October 2014 regarding the completion of the acquisition by Octopus Investments Limited of the Investment Adviser to MedicX Fund, MedicX Fund confirms that its Investment Adviser has changed its name, effective today, from MedicX Adviser Ltd to Octopus Healthcare Adviser Ltd.
There is no change to the name of MedicX Fund Limited or any of its subsidiary companies.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare +44 (0) 1483 869 500
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Canaccord Genuity Limited +44 (0) 20 7523 8000
Andrew Zychowski / Helen Goldsmith
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland / Sophie McNulty
Information on MedicX Fund Limited
MedicX Fund Limited (the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 137 primary healthcare properties.
The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of Octopus Healthcare Group. Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 32 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.